Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2084-2026

One Step pH in vitro diagnostic test REF: 31I4P Recall

One Step pH in vitro diagnostic test REF: 31I4P

FDA recall Class II

Ongoing

FDA lists this Class II recall for One Step pH in vitro diagnostic test REF: 31I4P. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2084-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 2, 2026
FDA report date
May 13, 2026
Quantity in commerce
7860 units
Distribution
See key details
FDA cause
No Marketing Application

What is being recalled?

One Step pH in vitro diagnostic test REF: 31I4P

Affected model & UDI checker

Search the exact identifiers published for Z-2084-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
31I4POne Step pH in vitro diagnostic test REF: 31I4PCheck source noticeNot specified
Not specifiedOne Step pH in vitro diagnostic test REF: 31I4PCheck source notice08806141303060
FDA code information

UDI: 08806141303060/ Lot: 250305, 250415, 250509, 250625, 250905

View the original FDA recall notice

Why was this product recalled?

The devices were distributed without required FDA premarket clearance or approval.

What actions did DFI Co., Ltd. take?

On April 2, 2026 Dream Future Innovation (DFI Co., Ltd.) issued a Urgent Medical Device Recall Notification to affected consignees via E. Mail. DFI ask consignees to take the following actions: 4.1 Distribution required Actions 1) Immediate Discontinuation: Immediately stop the use and distribution of the Products. 2) Inventory Quarantine: Quarantine all remaining inventory in a safe place and attach a NOT FOR SALE label. 3) Reply to Acknowledgement: Please fill out the attached Recall Acknowledgement Report and return it within 10 business days of receiving this notice 4) Sub-distributor Notification: Immediately notify all sub-distributors or end customers receiving Products. 4.2 End Customer required Actions 1) Stop using the product immediately. 2) Do not give or sell the product to anyone else. 3) Follow the instructions below regarding destruction or disposal. 4) Submit your refund / confirmation request as instructed. < Destruction / Disposal Instructions > To prevent accidental use, please cut the unused test strip(s) in half. After cutting the strips in half, please dispose of the destroyed components in accordance with your local municipal waste regulations

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology